SCHEMBL18022985

SCHEMBL18022985

CN(N)c1nc(-c2cccnc2)nc2ccc(-c3cccc(Cl)c3)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.52
CYP3A4 P08684 3/20 0.52
CYP2D6 P10635 3/20 0.52
CYP2C9 P11712 3/20 0.52
CLK4 Q9HAZ1 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 2/20 0.52
GLA P06280 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 2/20 0.47
LMNA P02545 1/20 0.47
HIF1A Q16665 1/20 0.47
PDE5A O76074 2/20 0.46
GBA1 P04062 13/20 0.46
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14475167 0.91 MEN1 (0.64) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL14474975 0.83 MEN1 (0.65) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL14475072 0.82 MAP4K4 (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL14475877 0.82 CLK4 (0.64) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL14475229 0.80 CYP1A2 (0.64) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL14475090 0.78 CYP1A2 (0.65) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL14475208 0.77 CYP1A2 (0.64) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL432877 0.77 MEN1 (0.57) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL16183452 0.77 CYP1A2 (0.64) CYP1A2CYP3A4CYP2D6CYP2C9CLK4
SCHEMBL14474105 0.77 MAPT (0.57) CYP1A2CYP3A4CYP2D6CLK4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3056207-A1 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE Otsuka Pharmaceutical Co., Ltd. (JP) 2016-08-17 EP disclosed